Jee AS, Sahhar J, Youssef P, Bleasel J, Adelstein S, Nguyen M, et al. Review: serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons. Pharmacol Ther. 2019;202:40–52.

Article  CAS  PubMed  Google Scholar 

Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46:795–806.

Article  PubMed  Google Scholar 

Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J. Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med. 2020;201:650–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Jiang Q, Wu P, Han L, Zhou P. Global incidence, prevalence and disease burden of silicosis: 30 years' overview and forecasted trends. BMC Public Health. 2023;23:1366.

Article  PubMed  PubMed Central  Google Scholar 

Alysandratos KD, Russo SJ, Petcherski A, Taddeo EP, Acin-Perez R, Villacorta-Martin C, et al. Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease. Cell Rep. 2021;36:109636.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stancil IT, Michalski JE, Davis-Hall D, Chu HW, Park JA, Magin CM, et al. Pulmonary fibrosis distal airway epithelia are dynamically and structurally dysfunctional. Nat Commun. 2021;12:4566.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Chen R, Li G, Wang Z, Liu J, Liang Y, et al. FBW7 mediates senescence and pulmonary fibrosis through telomere uncapping. Cell Metab. 2020;32(860–877):e869.

Google Scholar 

Katzen J, Beers MF. Contributions of alveolar epithelial cell quality control to pulmonary fibrosis. J Clin Invest. 2020;130:5088–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao Z, Lis R, Ginsberg M, Chavez D, Shido K, Rabbany SY, et al. Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis. Nat Med. 2016;22:154–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scruggs AM, Grabauskas G, Huang SK. The role of KCNMB1 and BK channels in Myofibroblast differentiation and pulmonary fibrosis. Am J Respir Cell Mol Biol. 2020;62:191–203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annual Review of Pathology-Mechanisms of Disease. 2022;17:515–46.

Article  CAS  Google Scholar 

Dempsey TM, Payne S, Sangaralingham L, Yao X, Shah ND, Limper AH. Adoption of the Antifibrotic medications Pirfenidone and Nintedanib for patients with idiopathic pulmonary fibrosis. Ann Am Thorac Soc. 2021;18:1121–8.

Article  PubMed  Google Scholar 

Shi X, Chen Y, Liu Q, Mei X, Liu J, Tang Y, et al. LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis. Clin Transl Med. 2022;12:e711.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Milara J, Navarro R, Juan G, Peiro T, Serrano A, Ramon M, et al. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Thorax. 2012;67:147–56.

Article  PubMed  Google Scholar 

Huang LS, Sudhadevi T, Fu P, Punathil-Kannan PK, Ebenezer DL, Ramchandran R, et al. Sphingosine kinase 1/S1P signaling contributes to pulmonary fibrosis by activating hippo/YAP pathway and mitochondrial reactive oxygen species in lung fibroblasts. Int J Mol Sci. 2020;21

Huang LS, Berdyshev EV, Tran JT, Xie L, Chen J, Ebenezer DL, et al. Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy. Thorax. 2015;70:1138–48.

Article  PubMed  Google Scholar 

Zhao J, Okamoto Y, Asano Y, Ishimaru K, Aki S, Yoshioka K, et al. Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages. PLoS ONE. 2018;13:e0197604.

Article  PubMed  PubMed Central  Google Scholar 

Summer R, Mora AL. Lipid metabolism: a new player in the conundrum of lung fibrosis. Am J Respir Cell Mol Biol. 2019;61:669–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Zhou S, Liu Y, Yu Y, Xu S, Peng L, et al. Exploration study on serum metabolic profiles of Chinese male patients with artificial stone silicosis, silicosis, and coal worker's pneumoconiosis. Toxicol Lett. 2022;356:132–42.

Article  CAS  PubMed  Google Scholar 

Dalleywater W, Powell HA, Hubbard RB, Navaratnam V. Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study. Chest. 2015;147:150–6.

Article  PubMed  Google Scholar 

Guo X, Sunil C, Qian G. Obesity and the development of lung fibrosis. Front Pharmacol. 2021;12:812166.

Article  CAS  PubMed  Google Scholar 

King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378:1949–61.

Article  PubMed  Google Scholar 

Chung KP, Hsu CL, Fan LC, Huang Z, Bhatia D, Chen YJ, et al. Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis. Nat Commun. 2019;10:3390.

Article  PubMed  PubMed Central  Google Scholar 

Martin M, Zhang J, Miao Y, He M, Kang J, Huang HY, et al. Role of endothelial cells in pulmonary fibrosis via SREBP2 activation. JCI Insight. 2021;6

Mould KJ, Moore CM, McManus SA, McCubbrey AL, McClendon JD, Griesmer CL, et al. Airspace macrophages and monocytes exist in transcriptionally distinct subsets in healthy adults. Am J Respir Crit Care Med. 2021;203:946–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colin S, Chinetti-Gbaguidi G, Staels B. Macrophage phenotypes in atherosclerosis. Immunol Rev. 2014;262:153–66.

Article  CAS  PubMed  Google Scholar 

Cheng P, Li S, Chen H. Macrophages in lung injury, repair, and fibrosis. Cells. 2021;10

Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20:163–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Valenzi E, Bulik M, Tabib T, Morse C, Sembrat J, Trejo Bittar H, et al. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease. Ann Rheum Dis. 2019;78:1379–87.

Article  CAS  PubMed  Google Scholar 

Reyfman PA, Walter JM, Joshi N, Anekalla KR, McQuattie-Pimentel AC, Chiu S, et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199:1517–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Habermann AC, Gutierrez AJ, Bui LT, Yahn SL, Winters NI, Calvi CL, et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci Adv. 2020;6:eaba1972.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adams TS, Schupp JC, Poli S, Ayaub EA, Neumark N, Ahangari F, et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv. 2020;6:eaba1983.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Larson-Casey JL, Deshane JS, Ryan AJ, Thannickal VJ, Carter AB. Macrophage Akt1 kinase-mediated Mitophagy modulates apoptosis resistance and pulmonary fibrosis. Immunity. 2016;44:582–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tlatelpa-Romero B, Cazares-Ordonez V, Oyarzabal LF, Vazquez-de-Lara LG. The role of pulmonary surfactant phospholipids in fibrotic lung diseases. Int J Mol Sci. 2022:24.

Yan F, Wen Z, Wang R, Luo W, Du Y, Wang W, et al. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics. BMC Pulm Med. 2017;17:174.

Article  PubMed  PubMed Central  Google Scholar 

Carter CL, Jones JW, Farese AM, MacVittie TJ, Kane MA. Lipidomic dysregulation within the lung parenchyma following whole-thorax lung irradiation: markers of injury, inflammation and fibrosis detected by MALDI-MSI. Sci Rep. 2017;7:10343.

Article  PubMed  PubMed Central  Google Scholar 

Nambiar S, Clynick B, How BS, King A, Walters EH, Goh NS, et al. There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF). Respir Res. 2021;22:105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vazquez de Lara LG, Tlatelpa-Romero B, Romero Y, Fernández-Tamayo N, Vazquez-de-Lara F, M. Justo-Janeiro J, et al. Phosphatidylethanolamine induces an Antifibrotic phenotype in Normal human lung fibroblasts and ameliorates Bleomycin-induced lung fibrosis in mice. Int J Mol Sci. 2018:19.

Preuss S, Scheiermann J, Stadelmann S, Omam FD, W